About Q Bio
Q Bio is a Healthcare company based in Redwood City (United States) founded in 2015 by Michael Snyder, Jeffrey Kaditz, and Garry Choy. Provider of clinical data management and analytics platform. Q Bio has raised $67.1 million across 4 funding rounds from investors including Khosla Ventures, Andreessen Horowitz and Founders Fund. The company has 27 employees. Its chief executive, as recorded, is Jeffrey Kaditz. Q Bio offers products and services including Gemini Exam and Digital Twin. Its focus areas include HealthTech, Healthcare IT, Horizontal and Collaboration Platforms. Its legal entity is Q BIO, INC. Its competitors include Briya, Seqster and Smartlink Health; 3 of its 3 listed competitors have raised funding.
Company details
Q Bio was founded in 2015 and is headquartered in Redwood City, United States. Operations focus on the health technology sector, where clinical data from various diagnostic sources is managed and analyzed. Solutions are developed to derive insights on physiology, with biomarkers examined across genetic, chemical, and anatomical datasets. The platform supports analytics for clinical relevance in stealth mode.
- Total Equity Funding$67.1M (USD)
in 4 rounds
- Latest Funding Round$27.1M (USD), Series B
Mar 2024
- InvestorsKhosla Ventures
& 6 more
- Employee Count27
Products & Services of Q Bio
Q Bio offers a comprehensive portfolio of products and services, including Gemini Exam and Digital Twin.
Streamlined physical exam integrating labs, genetics, and MRI for preventive care.
Uses data to create health models for proactive risk assessment and forecasting.
Funding Insights of Q Bio
Q Bio has successfully raised a total of $67.1M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $27.1 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $67.1M
- Total Rounds 4
- Last Round Series B — $27.1M
- Investors Count 7
All 4 funding rounds of Q Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2024 | $27.1M | Series B | – | a16z, Khosla Ventures | – |
| Apr 2021 | Series B | – | – | – | |
| Feb 2020 | $40M | Series B | – | a16z | |
| Nov 2016 | Seed | – | – |
7 investors in total: 7 institutional.
Investors in Q Bio
Q Bio has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Khosla Ventures, Andreessen Horowitz and Founders Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments in technology sectors are handled by Andreessen Horowitz. | a16z.com | |||
Early-stage startups are funded by this venture capital firm. | 2004 | khoslaventures.com | Menlo Park, United States | |
Venture capital investments in technology and defense sectors. | foundersfund.com | |||
Venture capital investments are provided to early-stage technology startups. | 2022 | beast.vc | ||
Limited information is provided about Sealane Ventures' activities. | sealaneventures.com | |||
Investments are directed toward early-stage consumer-tech startups. | scifi.vc | San Francisco, United States | ||
A family office for investments and media initiatives is managed. | 35v.tv |
Investor details for Q Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Q Bio
16 people are tracked at Q Bio (8 in leadership, 8 in team); the tracked headcount is 27.
| Name | Role | Group |
|---|---|---|
Michael Snyder | Co-Founder | Leadership |
Jeffrey Kaditz | Co-Founder & CEO | Leadership |
Garry Choy | Co-Founder & CMO | Leadership |
Alan Wang | Director Of Engineering | Leadership |
Katerina (Aikaterini) Kotrotsou, Ph.D. | Director Of Engineering | Leadership |
Garry Choy MD MBA | Co-Founder & Chief Medical Officer | Leadership |
Nancy Hong | Director Of Accounting | Leadership |
Thomas Witzel | VP of Radiomics | Leadership |
Victoria Shevchik | Software Engineer | Team |
Emil Baronov | Software Engineer | Team |
Alessandro Francavilla | Engineering Manager | Team |
Yinan Sun | Mechanical Engineer | Team |
Bruce Wong | Software Engineer | Team |
Laurel Stephenson Haskins | Machine Learning Engineer | Team |
Pedro Garzon | Staff Technical Program Manager / Engineering Manager | Team |
Karim Hasham | Product Advisor | Team |
Complete people profiles for Q Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Q Bio
3 dated milestones of Q Bio across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Q Bio is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $27.1M.
Competitors of Q Bio
Q Bio has 3 listed competitors in our database, 3 of them funded. They include Briya, Seqster and Smartlink Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| briya.com | 2021 | New York, United States | $17M | Cloud-based tools for medical data collaboration and management are provided. | ||
| seqster.com | 2016 | San Diego, United States | $12M | Online platform for managing and storing health records | ||
| smartlinkhealth.com | 2012 | Raleigh, United States | $7.8M | 16 | Patient medical information is extracted and shared securely by doctors. |
Detailed competitors of Q Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Q Bio
The website of Q Bio (q.bio) receives about 4.8K visits a month.
- Monthly visits4.8K
▲ 30.6% vs previous month
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Q Bio (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Q Bio
Complete news archive for Q Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Q Bio
Q Bio was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Q Bio is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Jeffrey Kaditz is the CEO of Q Bio, as recorded in our data. They have also founded this company.
Q Bio is a funded company, having raised a total of $67.1M across 4 funding rounds to date.
Q Bio has 27 employees.
Q Bio was founded in 2015 and is headquartered in Redwood City, United States. Operations focus on the health technology sector, where clinical data from various diagnostic sources is managed and analyzed. Solutions are developed to derive insights on physiology, with biomarkers examined across genetic, chemical, and anatomical datasets. The platform supports analytics for clinical relevance in stealth mode.
Q Bio's top competitors include Briya, Seqster and Smartlink Health.
Q Bio offers Gemini Exam and Digital Twin.
Q Bio has 7 investors. Key investors include Khosla Ventures, Andreessen Horowitz, Founders Fund, BEAST, and Sealane Ventures.
Q Bio operates through Q Bio, Inc..